ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2107

Deep Immunophenotyping of Knee Osteoarthritis Patients Reveals Alterations in T Cell, Treg, and Monocyte Subpopulations

Montana Barrett1, Gabby dyson2, Nicholas Hannebutt3, Aleksander Szymczak2, Cindy Miranda4 and Matlock Jeffries2, 1University of Oklahoma, Cement, OK, 2Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Spencer, OK, 4Oklahoma Medical Research Foundation, Yukon, OK

Meeting: ACR Convergence 2024

Keywords: Inflammation, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Previous studies have suggested low-level chronic inflammation plays a key role in knee osteoarthritis (OA) development and progression, although attention has mostly been focused on localized articular tissues. In the present study, we performed deep immunophenotyping via mass cytometry to better characterize peripheral blood immunophenotype changes in OA patients, including progressor subetypes.

Methods: OA patient and control blood samples were obtained from the Oklahoma SOONER OA cohort and Oklahoma Immune Cohort, respectively. Radiographic OA was defined as baseline K/L grade 2-3 and knee pain on most days for the past 6 months. Fixed-flexion radiographs and WOMAC information from visits every 6 months was analyzed. Joint space width measurements were determined using Image Biospy Lab’s KOALA software. Radiographic progressors were defined as having mean medial TF joint space narrowing of ≥0.7mm within 24 months. Controls were matched for age ±5 years, ethnicity, BMI ±5 units, and sex. The final analysis included 21 OA patients (15 radiographic nonprogressors and 6 radiographic progressors) and 11 disease-free controls. Baseline blood samples were stained with Maxpar Direct immune profiling assay kit (Fluidigm), then analyzed using OMIQ. Cell cluster assignment and analysis analysis of 37 canonical immune cell populations was performed using OMIQ. Group differences were computed using the EdgeR algorithm (overdispersed Poisson model followed by empirical Bayes method) with P≤0.05 defining statistical significance.

Results: OA patients were well matched with control subjects and among progressor groups, with no statistically significant differences in age, sex, BMI, baseline radiographic grade, or baseline WOMAC pain scores. Comparing all OA patients to controls using canonical cell subsets, we identified 7 subset differences (Figure 1A), with increases among OA patients in CD8 central memory cells (P=1E-4), Tregs (P=4E-4), and nonclassical monocytes (P=0.006), Figure 1A, 1C most prominent. Among OA patients comparing future radiographic progressors to future nonprogressors, we identified 3 subset differences, with decreases among rapid progressors in CD4 central memory cells (P=0.005), CD8 central memory cells (P=0.03), and CD8 terminal memory cells (P=0.03), Figure 1B.

Conclusion: Our study performed deep immunophenotyping of peripheral blood on a group of OA patients and well-matched controls. The results suggest that significant alterations in certain immune cell subpopulations are present among OA patients and at baseline prior to future radiographic progression and provide additional support for the hypothesis that OA represents a low-level systemic inflammatory disease. Future research should confirm our findings and investigate the pathophysiological consequences of these variations.

Supporting image 1


Disclosures: M. Barrett: None; G. dyson: None; N. Hannebutt: None; A. Szymczak: None; C. Miranda: None; M. Jeffries: None.

To cite this abstract in AMA style:

Barrett M, dyson G, Hannebutt N, Szymczak A, Miranda C, Jeffries M. Deep Immunophenotyping of Knee Osteoarthritis Patients Reveals Alterations in T Cell, Treg, and Monocyte Subpopulations [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/deep-immunophenotyping-of-knee-osteoarthritis-patients-reveals-alterations-in-t-cell-treg-and-monocyte-subpopulations/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deep-immunophenotyping-of-knee-osteoarthritis-patients-reveals-alterations-in-t-cell-treg-and-monocyte-subpopulations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology